Blevins, T. C., Barve, A., Raiter, Y., Aubonnet, P., Athalye, S., Sun, B., & Muniz, R. (2019). Efficacy and safety of MYL‐1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study. Diabetes Obes Metab.
Citação norma ChicagoBlevins, Thomas C., Abhijit Barve, Yaron Raiter, Patrick Aubonnet, Sandeep Athalye, Bin Sun, and Rafael Muniz. "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in People With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study." Diabetes Obes Metab 2019.
Citação norma MLABlevins, Thomas C., et al. "Efficacy and Safety of MYL‐1501D Versus Insulin Glargine in People With Type 1 Diabetes Mellitus: Results of the INSTRIDE 3 Phase 3 Switch Study." Diabetes Obes Metab 2019.